Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report
This case emphasizes the importance of thorough medication history-taking and structured causality assessment to distinguish between unregulated drug-induced liver injury and immune-related adverse events in cancer care. The use of social media to promote alternative therapies necessitates proactive patient counseling due to significant liver risks, and careful diagnostic evaluation can prevent unnecessary immunosuppression or treatment delays.
Authors
- Kaleb Lucas
- Arunkumar Krishnan (ORCID: https://orcid.org/0000-0002-9452-7377)
- Tinsay A Woreta
- Laura Maas
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Sinai Hospital (US)
- Levine Cancer Institute (US)
- Wake Forest University (US)
Publication Details
- Journal
- World Journal of Clinical Cases
- Published
- 2026-01-15
- DOI
- https://doi.org/10.12998/wjcc.v14.i2.116700
- Citations
- 1
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 52.25